3-(IMIDAZOL-4-YL)PROPIONIC ACID

CAS No. 1074-59-5

3-(IMIDAZOL-4-YL)PROPIONIC ACID( SALOR-INT L480258-1EA | Deamino-histidine | Imidazolylpropionic acid )

Catalog No. M28714 CAS No. 1074-59-5

3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 58 In Stock
500MG 138 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-(IMIDAZOL-4-YL)PROPIONIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.
  • Description
    3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination. 3-(IMIDAZOL-4-YL)PROPIONIC ACID is potent inhibitors of G. candidum histidinol dehydrogenase, showing IC50 values as low as 3.17 microM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SALOR-INT L480258-1EA | Deamino-histidine | Imidazolylpropionic acid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    leukotriene C4 (LTC4)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1074-59-5
  • Formula Weight
    140.142
  • Molecular Formula
    C6H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (713.57 mM)
  • SMILES
    OC(=O)CCc1c[nH]cn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Munck Af Rosensch?ld M, et al. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J Med Chem. 2019 Aug 30.
molnova catalog
related products
  • GSK864

    GSK864 is an IDH1 mutant inhibitor that inhibits IDH1 mutants R132C, R132H, and R132G, and is used in the study of cardiovascular and oncology diseases.

  • IDH889

    IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).

  • Mercaptopurine (6-MP...

    Mercaptopurine (6-mercaptopurine; 6-MP) is an immunosuppressive drug.